DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,042 filers reported holding DANAHER CORPORATION in Q1 2016. The put-call ratio across all filers is 0.83 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $46,000 | +1050.0% | 206 | +610.3% | 0.01% | +400.0% |
| Q1 2020 | $4,000 | -98.1% | 29 | -97.9% | 0.00% | -96.0% |
| Q4 2019 | $211,000 | +9.9% | 1,373 | +3.5% | 0.02% | +4.2% |
| Q3 2019 | $192,000 | +1.1% | 1,326 | 0.0% | 0.02% | -7.7% |
| Q2 2019 | $190,000 | +8.6% | 1,326 | 0.0% | 0.03% | +4.0% |
| Q1 2019 | $175,000 | +27.7% | 1,326 | 0.0% | 0.02% | +19.0% |
| Q4 2018 | $137,000 | -4.9% | 1,326 | 0.0% | 0.02% | +23.5% |
| Q3 2018 | $144,000 | +9.9% | 1,326 | 0.0% | 0.02% | +13.3% |
| Q2 2018 | $131,000 | +0.8% | 1,326 | 0.0% | 0.02% | 0.0% |
| Q1 2018 | $130,000 | +5.7% | 1,326 | 0.0% | 0.02% | +7.1% |
| Q4 2017 | $123,000 | +7.9% | 1,326 | 0.0% | 0.01% | +7.7% |
| Q3 2017 | $114,000 | +1.8% | 1,326 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $112,000 | -0.9% | 1,326 | 0.0% | 0.01% | +8.3% |
| Q1 2017 | $113,000 | +9.7% | 1,326 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $103,000 | -8.0% | 1,326 | -7.0% | 0.01% | -7.7% |
| Q3 2016 | $112,000 | -22.2% | 1,426 | 0.0% | 0.01% | -18.8% |
| Q2 2016 | $144,000 | +6.7% | 1,426 | 0.0% | 0.02% | 0.0% |
| Q1 2016 | $135,000 | +2.3% | 1,426 | 0.0% | 0.02% | 0.0% |
| Q4 2015 | $132,000 | +8.2% | 1,426 | 0.0% | 0.02% | +6.7% |
| Q3 2015 | $122,000 | 0.0% | 1,426 | 0.0% | 0.02% | +7.1% |
| Q2 2015 | $122,000 | -13.5% | 1,426 | -14.4% | 0.01% | -17.6% |
| Q1 2015 | $141,000 | +1466.7% | 1,666 | +1566.0% | 0.02% | +1600.0% |
| Q4 2014 | $9,000 | +12.5% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $8,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $8,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |